Stock 688137 NOVOPROTEIN SCIENTIFIC INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Novoprotein Scientific Inc.

Equities

688137

CNE100005NZ4

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 12/06/2024 am IST 		5-day change 1st Jan Change
34.4 CNY +1.56% Intraday chart for Novoprotein Scientific Inc. -0.52% -38.00%
28/04 Novoprotein Scientific Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
23/02 Novoprotein Scientific Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Novoprotein Scientific Inc is a China-based company mainly engaged in the provision of recombinant protein application solutions. The Company is mainly engaged in the research and development, production and sales of target and factor proteins, recombinant antibodies, enzymes and reagents, and the provision of related technical services. The Company's main products include novel coronavirus diagnostic antibodies, novel coronavirus diagnostic antigens, novel coronavirus pseudoviruses, novel coronavirus non-structural proteins and messenger ribonucleic acid (mRNA) raw materials enzymes and reagents. Its products and services are mainly used in biological medicine, basic research of life science, in vitro diagnosis, mRNA vaccine drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.

Number of employees: 579

Sales per Business

CNY in Million2022Weight2023Weight Delta
Enzymes and Reagents
45.7 %
132 49.9 % 70 45.7 % -47.02%
Target and Factor Proteins
38.9 %
57 21.6 % 60 38.9 % +4.50%
Clinical Research Organization Services
10.3 %
9 3.3 % 16 10.3 % +80.88%
Recombinant Antibodies
5.0 %
66 25.1 % 8 5.0 % -88.53%
Other Business
0.1 %
0 0.1 % 0 0.1 % -37.10%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.0 %
238 90.0 % 150 98.0 % -36.94%
Overseas
2.0 %
26 10.0 % 3 2.0 % -88.51%

Managers

Managers TitleAgeSince
Hua Xing Zhu CEO
 Chief Executive Officer 52 07/09/07
Dong Ye Zhang DFI
 Director of Finance/CFO 51 01/13/01
De Bin Li CHM
 Chairman 38 01/12/01
Li Lan Cui CTO
 Chief Tech/Sci/R&D Officer 34 01/15/01
Mi Wang BRD
 Director/Board Member 34 01/15/01
Qing Yi Zhang BRD
 Director/Board Member 39 01/11/01
Du Qiang Wang BRD
 Director/Board Member 39 01/10/01
Yu Jian Zhao BRD
 Director/Board Member 52 01/19/01
Ying Ming Wang BRD
 Director/Board Member 49 01/09/01
Wen Luo Zhang IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Fang Ping Zou BRD
 Director/Board Member 50 01/09/01
Xia Yun Song BRD
 Director/Board Member 55 15/21/15
Hua Xing Zhu CEO
 Chief Executive Officer 52 07/09/07
Yu Jian Zhao BRD
 Director/Board Member 52 01/19/01
You Chen Lu BRD
 Director/Board Member 48 01/19/01
Zong Xin Zhang BRD
 Director/Board Member 52 15/21/15
Jian Jin BRD
 Director/Board Member 64 15/21/15
De Bin Li CHM
 Chairman 38 01/12/01
Lin Hua BRD
 Director/Board Member 42 15/21/15
Qing Yi Zhang BRD
 Director/Board Member 39 01/11/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 70,175,439 16,424,379 ( 23.40 %) 0 23.40 %

Shareholders

NameEquities%Valuation
Huashang Fund Management Co., Ltd.
6.734 %
1,143,410 6.734 % 6 M ¥
Rongtong Fund Management Co., Ltd.
5.399 %
916,666 5.399 % 5 M ¥
Penghua Fund Management Co., Ltd.
1.768 %
300,149 1.768 % 1 M ¥
Orient Securities Asset Management Co. Ltd.
1.469 %
249,463 1.469 % 1 M ¥
Golden Trust Sinopac Fund Management Co., Ltd.
0.5557 %
94,347 0.5557 % 467 828 ¥
Western Leadbank Fund Management Co., Ltd
0.4514 %
76,646 0.4514 % 380 056 ¥
First-Trust Fund Management Co., Ltd.
0.1831 %
31,092 0.1831 % 154 172 ¥
Guotai Asset Management Co., Ltd.
0.1585 %
26,910 0.1585 % 133 436 ¥
China Merchants Fund Management Co., Ltd.
0.0926 %
15,721 0.0926 % 77 954 ¥
GF Fund Management Co., Ltd.
0.0692 %
11,750 0.0692 % 58 263 ¥
NameEquities%Valuation
Shanghai Sinobio Bio-Technology Co. Ltd.
57.06 %
30,355,000 57.06 % 151 M ¥
Wujiang Econ & Tech Devt Zone Mgmt Committee
19.02 %
10,120,000 19.02 % 50 M ¥
Suzhou Fanan Enterprise Management Partnership LP
7.444 %
3,960,000 7.444 % 20 M ¥
Suzhou Meian Enterprise Management Partnership LP
3.130 %
1,665,000 3.130 % 8 M ¥
Qiming Venture Partners Ltd.
2.968 %
1,578,947 2.968 % 8 M ¥
Suzhou Baan Enterprise Management Partnership LP
2.857 %
1,520,000 2.857 % 8 M ¥
Jolmo Capital Ltd.
2.688 %
1,430,000 2.688 % 7 M ¥
Shanghai Qiaobei Investment Management Enterprise LP
1.786 %
950,000 1.786 % 5 M ¥
Minsheng Securities Investment Co., Ltd.
1.062 %
565,024 1.062 % 3 M ¥
Shanghai Pujin Technology Development Partnership LP
0.4947 %
263,158 0.4947 % 1 M ¥

Company contact information

Suzhou Novoprotein Scientific Co., Ltd.

3/F-4/F No. 228 Yunchuang Road

215299, Suzhou

+

http://www.novoprotein.com.cn
address Novoprotein Scientific Inc.(688137)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
NOVOPROTEIN SCIENTIFIC INC. Stock Novoprotein Scientific Inc.
-38.00% 328M
CSL LIMITED Stock CSL Limited
-1.54% 91.26B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-2.37% 38.17B
UCB Stock UCB
+71.42% 26.74B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-12.31% 15.93B
INCYTE CORPORATION Stock Incyte Corporation
-4.54% 13.37B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-10.83% 11.77B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+180.20% 10.92B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-48.60% 10.27B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+1.42% 8.69B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 688137 Stock
  4. Company Novoprotein Scientific Inc.